Exploring the effects of COVID-19 on HIV and opioid use among people who inject drugs
When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States
This study looks at how the COVID-19 pandemic has affected people who inject drugs and their ability to get important health services that help prevent HIV, so we can better understand how to support them during tough times.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10906943 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic affects people who inject drugs (PWID) and their access to essential health services, particularly those aimed at preventing HIV. It aims to understand the potential resurgence of HIV infections among PWID due to disruptions in harm reduction services and antiretroviral therapy caused by the pandemic. By examining individual behaviors and social networks, the study seeks to identify factors that may contribute to increased vulnerability to HIV during this public health crisis. The findings could inform strategies to mitigate the impact of COVID-19 on this high-risk population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at risk for HIV, particularly those affected by the COVID-19 pandemic.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved interventions and policies that protect the health of people who inject drugs during pandemics.
How similar studies have performed: Previous research has shown that public health crises can significantly impact the health outcomes of vulnerable populations, suggesting that this approach is both relevant and necessary.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Genberg, Becky Lynn — Johns Hopkins University
- Study coordinator: Genberg, Becky Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.